Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

SAN FRANCISCO, Jan 12 (Reuters) - Pfizer is preparing for a consumer market for obesity drugs on par with the booming business it saw after it launched erectile dysfunction drug ​Viagra in 1998, CEO Albert Bourla said on Monday. Bourla said that even when the drugmaker was ‌negotiating its purchase of weight-loss drugmaker Metsera, initially announced in September 2025, Pfizer did not expect the cash-pay market for obesity drugs ‌currently dominated by Eli Lilly and Co and Novo Nordisk to get s